Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.
This prospective, multicenter, non-interventional study (NIS) seeks to evaluate treatment with nemolizumab of moderate-to-severe AD in adolescents and adults over an approximately 12-month period using physician assessments in routine clinical practice and PRO measures.
Treatment with nemolizumab will be determined solely by the participant's physician prior to study enrollment. No additional visits, procedures, or laboratory tests are required outside of routine clinical practice. The visit structure is not defined by the study protocol but is determined by routine medical practice. The visit schedule is intended to facilitate a systematic data assessment according to clinical routine. A sub-study will be completed in Germany and the UK at selected sites in which participants will complete the Peak Pruritus (PP) Numerical Rating Scale (NRS), Average Pruritus (AP) NRS, Sleep Disturbance (SD) NRS, and Pain NRS on a daily basis from Day -1 to Day 14. Data collection will occur remotely, and no clinic visits will be required.
Inclusion Criteria:
Exclusion Criteria:
clinical.studies@galderma.com817-961-5000
Fountain Valley, California 92708-3701, United States
Los Angeles, California 90024-2801, United States
Santa Monica, California 90404-2216, United States
Thousand Oaks, California 91360-7746, United States
North Miami Beach, Florida 33162-4708, United States
West Lafayette, Indiana 47906-1569, United States
Auburn Hills, Michigan 48326-3396, United States
Mount Kisco, New York 10549-3035, United States
Philadelphia, Pennsylvania 19103-4738, United States
Metropolitan Borough of Wirral, CH49 5PE, United Kingdom